Meta-analysis: An introduction and point of view

Hepatology

Volumn 23, Issue 4, 1996, Pages 917-928

  Friedman, Herman P ^a   Goldberg, Judith D ^b  

^a FORDHAM UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MEDICAL LITERATURE; MEDICAL RESEARCH; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

EID: 0029925881     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.ajhep0230917     Document Type: Editorial

References (9)

1. Wachter KW, Straf ML, eds. The future of meta-analysis. New York: Russell Sage Foundation, 1990.
2. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analysis of randomized control trials and recommendations of clinical experts. JAMA 1992;268:240-248.
3. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res 1976;6:3-8.
4. Goldberg JD, Koury KJ. Design and analysis of multicenter trials. In: Berry DA, ed. Statistical methodology in the pharmaceutical science. Chapter 8. New York: Marcel Dekker, 1992:201-237.
5. Canner PL. An overview of six clinical trials of aspirin in coronary heart disease. Stat Med 1987;6:255-263.
6. National Research Council. Combining information: statistical issues and opportunities for research. Washington, DC: National Academy Press, 1992.
7. Aldous P. A hearty endorsement for aspirin. Science 1994;263:24.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
9. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random effects regression model for meta-analysis. Stat Med 1995;14:395-411.